Analysis of quorum sensing-dependent virulence factor production and its relationship with antimicrobial susceptibility in Pseudomonas aeruginosa respiratory isolates

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
O Karatuna, Aysegul Yagci

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen causing severe respiratory infections. The pathogenesis of these infections is multifactorial and the production of many virulence factors is regulated by quorum sensing (QS), a cell-to-cell communication mechanism. The two well defined QS systems in P. aeruginosa, the las and rhl systems, rely on N-acyl homoserine lactone signal molecules, also termed autoinducers. We assessed the activity of QS-dependent virulence factors (including elastase, alkaline protease, pyocyanin and biofilm production) in respiratory isolates of P. aeruginosa and their relationship with antimicrobial susceptibility. We identified sixteen isolates displaying impaired phenotypic activity; among them, eleven isolates were also defective in autoinducer production, and therefore considered QS-deficient. Six of the QS-deficient isolates failed to amplify one or more of the four QS regulatory genes (lasI, lasR, rhlI, rhlR) with PCR: one isolate was negative for rhlR, two isolates were negative for rhlI and rhlR and three isolates were negative for all four genes. The isolates that were negative for virulence factor production were generally less susceptible to the antimicrobials and statistically significa...Continue Reading

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Feb 10, 2004·Journal of Clinical Microbiology·Valérie DénervaudChristian van Delden
Jan 28, 2005·Postgraduate Medicine·Alan R Hauser, Padman Sriram
Jan 13, 2006·Trends in Microbiology·Victoria E WagnerBarbara H Iglewski
Feb 14, 2006·FEMS Microbiology Reviews·Vittorio Venturi
Mar 1, 2006·International Journal of Medical Microbiology : IJMM·Karin HeurlierDieter Haas
May 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eric E SmithMaynard V Olson
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R Le BerreUNKNOWN Pyopneumagen Group
Apr 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Thilo KöhlerChristian van Delden

❮ Previous
Next ❯

Citations

Jan 16, 2014·Indian Journal of Microbiology·Dhamodharan BakkiyarajShunmugiah Karutha Pandian
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Stefanie LimmerDominique Ferrandon
Aug 21, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Bryan J WilliamsTimothy S Blackwell
Nov 12, 2013·World Journal of Microbiology & Biotechnology·Sheeba JayaseelanSelvakumar Dharmaraj
Jan 11, 2014·Environmental Science and Pollution Research International·Raphaël LavenirBenoit Cournoyer
Apr 2, 2013·Nature Chemical Biology·Jasmine LeeLian-Hui Zhang
Aug 16, 2014·International Journal of Medical Microbiology : IJMM·Lívia V SilvaAndré L S Santos
Feb 24, 2012·Journal of Basic Microbiology·Khadar Syed MusthafaArumugam Veera Ravi
Jun 12, 2013·Ultrasonics Sonochemistry·Matteo ErriuGermano Orrù
May 13, 2015·Jundishapur Journal of Microbiology·Samira Heydari, Fereshteh Eftekhar
May 10, 2016·Burns : Journal of the International Society for Burn Injuries·Samah MeradjiMohammed Timinouni
May 21, 2016·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·André Pitondo-SilvaEliana Guedes Stehling
Jul 28, 2016·Current Microbiology·Tsiry Rasamiravaka, Mondher El Jaziri
Mar 16, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Khadar Syed MusthafaSupayang Piyawan Voravuthikunchai
Mar 9, 2017·Microorganisms·Amin OmarPatricia Nadworny
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Veronica N KosHumphrey A Gardner
Jun 13, 2019·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Hossein JamalifarMohammad Reza Fazeli
May 22, 2010·Microbiology·L Caetano M AntunesB Brett Finlay
Feb 29, 2020·Infection and Drug Resistance·Noha A HassunaEbtisam Samir Mohamed
Aug 6, 2015·World Journal of Clinical Cases·Israel Castillo-JuárezRodolfo García-Contreras
Dec 19, 2019·Frontiers in Chemistry·Anthony D VerderosaKathryn E Fairfull-Smith
Mar 7, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Yiwen WangHaiwei Song
Mar 7, 2017·Frontiers in Cellular and Infection Microbiology·M Fata MoradaliBernd H A Rehm
Oct 29, 2020·Revista Da Sociedade Brasileira De Medicina Tropical·Rodrigo Lira RodriguesMaria Amélia Vieira Maciel
Oct 24, 2020·Antibiotics·Virginio Cepas, Sara M Soto
Mar 20, 2021·World Journal of Microbiology & Biotechnology·Vijayakumar KaruppiahGunasekaran Thangaraj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

Journal of Infection in Developing Countries
Sezgi SenturkAysegul Yagci
Biotechnology and Bioengineering
D de BeerZ Lewandowski
International Journal of Antimicrobial Agents
Niels HøibyOana Ciofu
© 2021 Meta ULC. All rights reserved